Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
The results of the final protocol-defined analysis of the PALLAS study conducted in patients with early hormone receptor-positive, HER2-negative breast cancer
Efficacy was evaluated in KEYNOTE-716 study
In a prespecified RxPONDER analysis, postmenopausal women with 1 to 3 positive axillary lymph nodes and a recurrence score of 0 to 25 were able to safely forgo adjuvant chemotherapy for breast cancer
Retrieval of previously unreported data of PD-L1 subgroups from pivotal phase III randomised studies
When classified into gain-of-function and non–gain-of-function, p53 mutations could stratify the prognosis of right-sided versus left-sided metastatic colorectal cancer
Efficacy was evaluated in a single-arm cohort of PLEIADES study
The results from an open-label phase II study in patients with carcinoma of unknown primary
The results from a head-to-head comparison of two different neurokinin-1 receptor antagonists for the prevention of chemotherapy induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
Longest median overall survival in a phase III melanoma study reported to date and the first report of melanoma-specific survival
Efficacy was evaluated in AMPECT study in patients with locally advanced unresectable or metastatic malignant PEComa
Withdrawal concerns application to use Cervarix in individuals from the age of 9 years for the prevention of head and neck cancers
The results from a randomised, phase III DAWNA-1 study with a new, orally administered, selective CDK4/6 inhibitor
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
